Medical Cannabis Laws and Opioid Analgesic Overdose Mortality in the United States, 1999-2010
This originally appeared at https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/1898878 October 2014 Marcus A. Bachhuber, MD1,2,3; Brendan Saloner, PhD3,4; Chinazo O. Cunningham, MD, MS5; et alColleen L. Barry, PhD, MPP3,6 JAMA Intern Med. 2014;174(10):1668-1673. doi:10.1001/jamainternmed.2014.4005 Abstract Importance Opioid analgesic overdose mortality continues to rise in the United States, driven by increases in prescribing for chronic pain. Because chronic pain is a major indication for medical cannabis, laws that establish access to medical cannabis may […]
Intermittent Marijuana Use Is Associated with Improved Retention in Naltrexone Treatment for Opiate-Dependence
This originally appeared at https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2753886/ Am J Addict. Author manuscript; available in PMC 2009 Sep 29. Published in final edited form as: Am J Addict. 2009 Jul–Aug; 18(4): 301–308. doi: 10.1080/10550490902927785PMCID: PMC2753886NIHMSID: NIHMS141953PMID: 19444734 Intermittent Marijuana Use Is Associated with Improved Retention in Naltrexone Treatment for Opiate-Dependence Wilfrid Noel Raby, PhD, MD, Kenneth M. Carpenter, PhD, Jami Rothenberg, PhD, Adam C. Brooks, PhD, Huiping […]
Substituting cannabis for prescription drugs, alcohol and other substances among medical cannabis patients: The impact of contextual factors
This article originally appeared at https://onlinelibrary.wiley.com/doi/abs/10.1111/dar.12323 First published: 14 September 2015 Abstract Introduction and Aims Recent years have witnessed increased attention to how cannabis use impacts the use of other psychoactive substances. The present study examines the use of cannabis as a substitute for alcohol, illicit substances and prescription drugs among 473 adults who use […]
Medical Marijuana Legalization Linked To ‘Significant Decrease’ In Opioid-Related Payments To Doctors, Study Finds
This article originally appeared at https://www.marijuanamoment.net/medical-marijuana-legalization-linked-to-significant-decrease-in-opioid-related-payments-to-doctors-study-finds/ A new study is linking state-level medical marijuana legalization to reduced opioid payouts to doctors—another datapoint suggesting that patients use cannabis as an alternative to prescription drugs when given legal access. The study from researchers at the University of Florida, University of Southern California and Purdue University identified “a […]
Medical Marijuana Legalization and Opioid- and Pain-Related Outcomes Among Patients Newly Diagnosed With Cancer Receiving Anticancer Treatment
This article originally appeared at https://jamanetwork.com/journals/jamaoncology/article-abstract/2799132 Authors Yuhua Bao, PhD1,2; Hao Zhang, PhD1; Eduardo Bruera, MD3; et alRussell Portenoy, MD4,5,6; William E. Rosa, PhD, MBE, APRN7; M. Carrington Reid, MD, PhD8; Hefei Wen, PhD9 JAMA Oncol. 2023;9(2):206-214. doi:10.1001/jamaoncol.2022.5623 Key Points Question Is medical marijuana legalization associated with opioid-related and pain-related outcomes for adult patients newly diagnosed with cancer and receiving anticancer treatment? Findings This cross-sectional study of 38 189 patients […]
Medical Cannabis Patients Report Improvements in Health Functioning and Reductions in Opiate Use
This article originally appeared at https://www.tandfonline.com/doi/full/10.1080/10826084.2022.2107673 Abstract Purpose: Opioid use rates have dropped as North American patients gain access to medical cannabis, indicating a harm reduction role, yet health outcomes remain mostly unexplored. This study presents self-reported medical cannabis use, perceptions of health functioning, and changes in opioid pain medication use in Florida medical cannabis […]
Medical Marijuana Legalization and Opioid- and Pain-Related Outcomes Among Patients Newly Diagnosed With Cancer Receiving Anticancer Treatment
This article originally appeared at https://jamanetwork.com/journals/jamaoncology/article-abstract/2799132 Yuhua Bao, PhD1,2; Hao Zhang, PhD1; Eduardo Bruera, MD3; et alRussell Portenoy, MD4,5,6; William E. Rosa, PhD, MBE, APRN7; M. Carrington Reid, MD, PhD8; Hefei Wen, PhD9 JAMA Oncol. 2023;9(2):206-214. doi:10.1001/jamaoncol.2022.5623 Key Points Question Is medical marijuana legalization associated with opioid-related and pain-related outcomes for adult patients newly diagnosed with cancer and receiving anticancer treatment? Findings This cross-sectional study of 38 189 patients with […]
